United-Guardian Reports Third Quarter Financial Results

Rhea-AI Summary

United-Guardian (NASDAQ:UG) reported a 42% rise in net income for Q3 2021, reaching $1,016,506 ($0.22 per share), compared to $717,532 ($0.16) in Q3 2020. Net sales surged by 36% to $3,179,746, up from $2,336,360. For the first nine months of 2021, net income increased by 31% to $3,542,232 ($0.77 per share), with sales climbing 19% to $10,268,592. Cosmetic ingredient sales multiplied by 187%, boosted by a 300% increase from a partner in Asia. Despite ongoing supply chain challenges, the company anticipates continued growth into 2022.

Positive

• Net income increased by 42% in Q3 2021.
• Q3 2021 net sales rose 36% compared to Q3 2020.
• Sales of cosmetic ingredients surged by 187% in Q3 2021.
• Net income for the first nine months increased by 31%.

Negative

• Ongoing supply chain and shipping issues may affect future performance.

HAUPPAUGE, N.Y., Nov. 10, 2021 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported today that net income for the third quarter of 2021 increased by 42% over the same quarter in 2020, increasing from $717,532 ($0.16 per share) in 2020 to $1,016,506 ($0.22 per share) in this year’s third quarter. Net sales for the quarter increased by 36% from $2,336,360 in 2020 to $3,179,746 this year. For the first nine months 2021, net income increased from $2,694,450 ($0.59 per share) in 2020 to $3,542,232 ($0.77 per share) this year, an increase of 31%, while net sales increased from $8,613,918 in 2020 to $10,268,592 in 2021, an increase of 19%.

Ken Globus, President of United-Guardian, stated, “As we had anticipated, sales of our cosmetic ingredients in this year’s third quarter increased substantially over the third quarter of 2020, which was when the impact of the global coronavirus pandemic was most severe. Sales of our cosmetic ingredients in this year’s third quarter increased by 187% over the comparable quarter last year, with sales to our marketing partner in Asia, Ashland Specialty Ingredients, increasing by over 300%, and sales to our four other marketing partners in Europe all increasing compared with last year. While we expect to continue to be impacted to some extent by the global pandemic, we anticipate that the impact will relate primarily to supply chain and shipping issues, increasing some lead times and raw material costs. As the impact of the global pandemic continues to lessen, and as we continue to introduce new products into both the cosmetic and medical markets, we are hopeful that our sales will continue to increase into 2022. We are confident that despite the lingering effects of the pandemic, we will end the year with financial results that will be significantly better than in 2020.”

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

Contact: Ken Globus                 
Investor Relations
(631) 273-0900

NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.

STATEMENTS OF INCOME
FOR THE
THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2021 and 2020*
(UNAUDITED)           

	THREE MONTHS ENDED SEPTEMBER 30,						NINE MONTHS ENDED        SEPTEMBER 30,
	2021			2020			2021			2020
Net Sales	$	3,179,746		$	2,336,360		$	10,268,592		$	8,613,918
Costs and expenses:
Cost of sales		1,320,509			974,763			4,180,912			3,634,528
Operating expenses		458,582			493,204			1,428,721			1,520,114
Research and development		130,742			114,836			349,053			331,134
Total costs and expenses		1,909,833			1,582,803			5,958,686			5,485,776
Income from operations		1,269,913			753,557			4,309,906			3,128,142
Other Income:
Investment income		38,747			38,932			124,147			131,318
Net (loss) gain on marketable securities		(25,108)			113,248			40,419			143,832
Total other income		13,639			152,180			164,566			275,150
Income before provision for income taxes		1,283,552			905,737			4,474,472			3,403,292
Provision for income taxes		267,046			188,205			932,240			708,842
Net Income	$	1,016,506		$	717,532		$	3,542,232		$	2,694,450
Earnings per common share (Basic and Diluted)	$	0.22		$	0.16		$	0.77		$	0.59
Weighted average shares – basic      and diluted		4,594,319			4,594,319			4,594,319			4,594,319

_* Additional financial information can be found at the company’s web site at www.u-g.com.

FAQ

What were United-Guardian's earnings for Q3 2021?

United-Guardian reported net income of $1,016,506 for Q3 2021, which is $0.22 per share.

How did United-Guardian's net sales perform in Q3 2021?

Net sales for Q3 2021 were $3,179,746, a 36% increase from Q3 2020.

What is the sales growth percentage for United-Guardian's cosmetic ingredients in Q3 2021?

Sales of cosmetic ingredients increased by 187% in Q3 2021 compared to the same period last year.

What are the financial results for the first nine months of 2021 for United-Guardian?

For the first nine months of 2021, United-Guardian reported a net income of $3,542,232 and net sales of $10,268,592.